Vancouver and Dubai-based investor Yazan Al Homsi says Rocket Doctor AI’s newly announced California provider-network agreement adds a new test to an investment thesis he has focused on for months: that the company’s long-term opportunity may depend less on conventional telehealth growth than on infrastructure for reimbursed physician-led care. Al Homsi discloses an equity interest in Rocket Doctor AI held through Founders Round Capital, as an investor only with no operating role. “The 60 million figure gets attention, but that isn’t the number I’m underwriting,” said Al Homsi. “What matters is whether broader network access converts into physician activity, patient encounters and reimbursed revenue.”
Browsing: Yazan Al Homsi
“The number that matters most to me isn’t the yield percentage, it’s the two hours it took the team to get back to steady state after they deliberately threw the process off balance,” said Yazan Al Homsi. “That kind of process control only comes from repetition, not a single good test.”